Search Results - "Lytkina, K A"

Predictors of biologic disease modifying antirheumatic drugs withdrawal due to the development of adverse events in patients with rheumatoid arthritis by Koltsova, E. N., Lukina, G. V., Schmidt, E. I., Lytkina, K. A., Zhilyaev, E. V.

“…Currently, a large number of highly effective biologic disease modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) are used for…”
Get full text

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol by Karateev, Dmitry Evgenyevich, Nasonov, E L, Denisov, L N, Stanislav, M L, Panasyuk, E Yu, Andrianova, I A, Mazurov, V I, Zhugrova, E S, Uspensky, Yu P, Belousova, L N, Ilivanova, E P, Matsiyevskaya, G K, Aurtyunov, G P, Lytkina, K A, Saikovsky, R S, Ardashev, V N, Zhilyaev, E V, Korshunov, N I

“…Certolizumab pegol (CZP) is a new drug from the group of tumor necrosis factor a inhibitors. The efficacy and safety CZP in the treatment of rheumatoid…”
Get full text

Vliyanie korotkogo kursa terapii movalisom na kachestvo zhizni patsientov s osteoartrozom by K A Lytkina, V V Tsurko, P A Vorob'ev

“…Tsel' issledovaniya. Otsenivali vliyanie korotkogo kursa terapii movalisom na kachestvo zhizni patsientov s osteoartrozom. Materialy i metody. Dlya…”
Get full text

Targeted anti-inflammatory therapy effect on various indicators of the psoriatic arthritis activity: Moscow Unified Arthritis Registry (MUAR) data by Lytkina, K.A., Lukina, G.V., Koltsova, E.N., Shmidt, E.I., Zhilyaev, E.V.

“…Background: the number of genetically engineered biological drugs and targeted synthetic drugs for the treatment of psoriatic arthritis (PA) is rapidly…”
Get full text

Comparative efficacy of genetically engineered biological drugs in real clinical practice according to the Moscow Unified Arthritis Registry (MUAR) data by Rosochkina, E.A., Lukina, G.V., Koltsova, E.N., Lytkina, K.A., Shmidt, E.I., Zagrebneva, A.I., Zhilyaev, E.V.

“…Background: the list expansion of genetically engineered biological drugs (GEBD) used for the treatment of ankylosing spondylitis (AS) determines the relevance…”
Get full text

Vliyanie korotkogo kursa terapii movalisom na kachestvo zhizni patsientov s osteoartrozom by K A Lytkina, V V Tsurko, P A Vorob'ev

“…Tsel' issledovaniya. Otsenivali vliyanie korotkogo kursa terapii movalisom na kachestvo zhizni patsientov s osteoartrozom. Materialy i metody. Dlya…”
Get full text